.png)
Key Takeaways
- GeneDx’s Clinical Billing Integrity team brings together clinical, coding, credentialing, contract operations, and revenue cycle expertise to support billing integrity across the genetic testing claim lifecycle.
- Establishing medical necessity and providing required clinical documentation early can help health plans make more informed coverage decisions upfront.
- Accurate CPT/ICD-10 coding and alignment with payor requirements can help reduce denied claims, repeated documentation requests, and administrative rework.
- GeneDx’s proactive approach is designed to prevent billing issues before they occur while supporting timely access to medically necessary genetic testing.
How Clinical Billing Integrity Supports Genetic Testing Claims
In molecular pathology and genetic testing, accurate claims processing is essential to both patient access and administrative efficiency. When prior authorizations or claims are incomplete, misaligned with policy, or submitted without the right documentation, the result can be denied claims, avoidable appeals, and delays in care.
At GeneDx, the Clinical Billing Integrity (CBI) team was built to address these challenges proactively, serving as a bridge between clinical excellence and revenue cycle performance to ensure claims are accurate, well-supported, and aligned with payor expectations from the start.
A Cross-Functional Approach to Billing Integrity
What makes the CBI team distinctive is its cross-functional foundation. It's led by genetic counselors with experience in both direct patient care and large payor organizations, a combination that brings deep understanding of the clinical context behind genetic testing and the policy frameworks that guide coverage decisions. CBI also includes experienced medical coding professionals, contract operations specialists, and payor credentialing experts. Together, these disciplines move billing beyond a traditional "bill and appeal" model toward one built on accuracy, transparency, and upfront alignment.
Getting Genetic Testing Claims Right the First Time
The CBI team's mission is twofold: help patients access their insurance benefits for medically necessary testing and reduce administrative burden for GeneDx and payor partners alike.
That starts with establishing medical necessity as early as possible, ideally before a claim is ever generated. By educating ordering providers on exactly what documentation payors require, GeneDx can submit clinical records earlier, often during prior authorization, giving health plans what they need to make informed coverage decisions upfront.
Coding accuracy is equally critical. Molecular pathology coding is highly specialized, and GeneDx's coding experts ensure testing is represented in line with payor expectations and CPT/ICD-10 standards, helping guarantee internal systems reflect accurate pricing, contract terms, and coding requirements. Together, this upfront rigor reduces denied claims, repeated documentation requests, and lengthy appeals.
Supporting Billing Integrity Across the Claim Lifecycle
The CBI team's strength lies in supporting billing integrity at every stage:
- Clinical Billing Integrity Analysts conduct medical necessity reviews and apply payor clinical policies to inform billing strategy.
- Medical Coding Professionals support precise diagnosis reporting and accurate procedural coding.
- Credentialing Experts verify providers and services are properly enrolled with payors, reducing administrative delays.
- Revenue Cycle Contracts Management oversees fee schedules, payor contracts, and test menu alignment, so internal systems reflect payor structures accurately.
Together, these functions help GeneDx prevent issues upfront instead of resolving them after they occur.
A More Collaborative Path Forward for Health Plans
GeneDx is committed to being a responsible, collaborative partner to health plans. Through accurate coding, comprehensive documentation, and clear contractual alignment, the Clinical Billing Integrity team helps support timely patient access to medically necessary genetic testing, while enabling health plans to make faster, better-informed coverage decisions.
